N0874: Phase I/II Study of Vorinostat (Suberoylanilide Hydroxamic Acid [SAHA]), Temozolomide, and Radiation Therapy in Patients with Newly Diagnosed Glioblastoma

Grant

Total Award Amount

  • 6000.00
  • Direct Costs

  • 4096.00
  • Sponsor Award Id

  • Contributor

  • Louis Nabors M.D.   Principal Investigator